Tenaya Therapeutics (TNYA) Prepaid Assets (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Prepaid Assets of $5.0 million for Q1 2026, down 20.21% year-over-year from $6.3 million in Q1 2025, and up 392.49% quarter-over-quarter from $1.0 million in Q4 2025.
Tenaya Therapeutics (TNYA) Prepaid Assets (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 20.21% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (down 20.21% YoY), while the FY2025 annual figure was $1.0 million, down 82.71% from the prior year.
- Prepaid Assets for Q1 2026 stood at $5.0 million, up from $1.0 million in the prior quarter.
- The five-year high for Prepaid Assets was $7.6 million in Q3 2022, with the low at $218000.0 in Q2 2025.
- The 5-year median for Prepaid Assets is $5.0 million (2026), against an average of $4.2 million.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets soared 639.87% in 2023, then slumped 84.5% in 2025.
- Tenaya Therapeutics' Prepaid Assets stood at $938000.0 in 2022, then jumped by 639.87% to $6.9 million in 2023, then decreased by 14.57% to $5.9 million in 2024, then sank by 82.71% to $1.0 million in 2025, then soared by 392.49% to $5.0 million in 2026.
- Business Quant data shows TNYA's Prepaid Assets at $5.0 million in Q1 2026, $1.0 million in Q4 2025, and $990000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenaya Therapeutics | 151.50 Mn | 151.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.55 Mn |
| Mar 31, 2026 | 5.05 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | 990,000.00 |
| Jun 30, 2025 | 218,000.00 |
| Mar 31, 2025 | 6.33 Mn |
| Dec 31, 2024 | 5.93 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 6.45 Mn |
| Dec 31, 2023 | 6.94 Mn |
| Sep 30, 2023 | 5.08 Mn |
| Jun 30, 2023 | 6.40 Mn |
| Mar 31, 2023 | 6.82 Mn |
| Dec 31, 2022 | 938,000.00 |
| Sep 30, 2022 | 7.62 Mn |
| Jun 30, 2022 | 4.78 Mn |
| Mar 31, 2022 | 3.33 Mn |
| Dec 31, 2021 | 4.06 Mn |
| Sep 30, 2021 | 4.36 Mn |